Abstract Response Evaluation Criteria In Solid Tumours (RECIST) remain an integral part of
the assessment of tumour burden in many clinical trials in oncology; these criteria are used …

Purpose Improvement of the therapeutic approaches in gastrointestinal stromal tumors
(GIST) by the introduction of targeted therapies requires appropriate diagnostic tools, which …

The management of gastrointestinal stromal tumors (GISTs) has evolved significantly in the
last two decades due to better understanding of their biologic behavior as well as …

Gastrointestinal stromal tumors (GISTs) are rare mesenchymal neoplasms. Tyrosine kinase
inhibitor (TKI) therapy is currently part of routine clinical practice for unresectable and …

Purpose: To build a dual-energy computed tomography (DECT) delta radiomics model to
predict chemotherapeutic response for far-advanced gastric cancer (GC) patients. A semi …

Background Immune checkpoint inhibitors have emerged as a standard of care treatment for
non-small cell lung cancer (NSCLC). To get insight into variations in tumour growth kinetics …

Objectives To validate estimated tumour volumetry in primary gastric gastrointestinal stromal
tumours (GISTs) using semiautomated volumetry. Methods In this IRB-approved …

Introduction: Gastrointestinal stromal tumor (GIST) is the most common malignant
mesenchymal tumor of the gastrointestinal system. Multiple advances in the management of …

Patients with gastro‐intestinal stromal tumors (GISTs) undergoing tyrosine kinase inhibitor
therapy are monitored with regular computed tomography (CT) scans, exposing patients to …

Background Tumor growth rate (TGR), denoted as percentage change in tumor size per
month, is a well-established indicator of tumor growth kinetics. The predictive value of early …